Antithrombin III for portal vein thrombosis in patients with liver disease: A randomized, double‐blind, controlled trial
Hepatology Research2017Vol. 48(3), pp. E107–E116
Citations Over TimeTop 14% of 2017 papers
Hisashi Hidaka, Shigehiro Kokubu, Takahiro Sato, Shinji Katsushima, Namiki Izumi, Takumi Igura, Shingo Asahara, Kazuo Notsumata, Yukio Osaki, Keiji Tsuji, Hirofumi Kawanaka, Tomohiko Akahoshi, Shozo Hirota, Shoichi Matsutani, The NPB‐06 study group
Abstract
Antithrombin III is one of the essential therapies for patients with PVT in cases with lower concentration levels of AT-III.
Related Papers
- → Seasonal variations of deep vein thrombosis and its influence on the location of the thrombus(2002)33 cited
- [Clinical symptoms and phlebographic findings in acute leg thrombosis].(1970)
- Correlation between thrombosis and density(2006)
- Model for Dynamic Study of Deep Venous Thrombosis in Rats(2008)
- → Liver Transplantation in Patients with Pre-Existing Portal Vein Thrombosis(2018)